MACRO Clinical Trial Manager
I took on the role of the MACRO Trial Manager in January 2020. The MACRO Trial is an ENT study, which aims to produce evidence about the effectiveness and role of medical treatment (long-term antibiotics) and sinus surgery in adults with Chronic Rhinosinusitis (CRS) both with and without polyps.
I originally joined SITU as the UK TAVI Trial Manager in March 2018. UK TAVI is an NIHR HTA funded multicentre randomised controlled trial to assess the clinical effectiveness and cost-utility of TAVI compared with conventional surgical AVR in patients with severe symptomatic aortic stenosis at intermediate or high operative risk.
Prior to this, I worked as the Clinical Trial Administrator on the AspECT Trial for the Oncology Clinical Trials Office in the University of Oxford.